Rare diseases
Investigational molecules
Locations
400 Oyster Point Boulevard Suite 520, 94080-1921, United States
Clinical research is centred on metastatic castration-resistant prostate cancer, with a focus on disease control in men whose cancer has progressed despite standard hormonal suppression.
The sponsor’s activity in this area reflects interest in treatment-resistant prostate disease and the search for more effective oncology options.
Essa Pharma Inc. runs clinical trials in conditions such as Hormone-refractory prostate cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
